FAM
Formidable Asset Management’s United Therapeutics UTHR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $592K | Buy |
2,060
+97
| +5% | +$27.9K | 0.1% | 201 |
|
2025
Q1 | $605K | Hold |
1,963
| – | – | 0.1% | 199 |
|
2024
Q4 | $693K | Buy |
1,963
+504
| +35% | +$178K | 0.11% | 171 |
|
2024
Q3 | $523K | Sell |
1,459
-108
| -7% | -$38.7K | 0.08% | 218 |
|
2024
Q2 | $499K | Sell |
1,567
-1,811
| -54% | -$577K | 0.08% | 234 |
|
2024
Q1 | $777K | Sell |
3,378
-172
| -5% | -$39.5K | 0.13% | 169 |
|
2023
Q4 | $781K | Sell |
3,550
-86
| -2% | -$18.9K | 0.16% | 119 |
|
2023
Q3 | $821K | Buy |
3,636
+53
| +1% | +$12K | 0.18% | 105 |
|
2023
Q2 | $791K | Buy |
3,583
+354
| +11% | +$78.2K | 0.17% | 116 |
|
2023
Q1 | $723K | Buy |
3,229
+1,399
| +76% | +$313K | 0.15% | 130 |
|
2022
Q4 | $509K | Sell |
1,830
-500
| -21% | -$139K | 0.12% | 162 |
|
2022
Q3 | $491K | Buy |
2,330
+51
| +2% | +$10.7K | 0.11% | 159 |
|
2022
Q2 | $536K | Buy |
2,279
+139
| +6% | +$32.7K | 0.12% | 157 |
|
2022
Q1 | $384K | Sell |
2,140
-43
| -2% | -$7.72K | 0.07% | 223 |
|
2021
Q4 | $472K | Buy |
+2,183
| New | +$472K | 0.09% | 194 |
|